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Summary 
Hybrid human-mouse Thy-l.1 genes were injected 
into pronuclei of Thy-l.2 mice to produce transgenic 
animals. A hybrid gene composed of the 5’ part of the 
mouse Thy-l.1 gene combined with the 3’ human un- 
translated regions was expressed abnormally in the 
kidney podocytes, which resulted in severe protein- 
uria and subsequent death in several founder mice. A 
hybrid Thy-l gene composed of the human coding re- 
gion with the 5’ and 3’ flanking regions of the mouse 
gene was expressed abnormally in a different part bf 
the kidney (the tubular epithelia), which resulted in a 
proliferative kidney disorder. In addition, a neoplasm 
was found in the brain of one of these mice. These 
results show that the Thy-l protein can play an impor- 
tant role in the activation, proliferation, and differenti- 
ation of many different cell types. 
Introduction 
The Thy-l gene is a member of the lg superfamily of 
genes (Williams, 1985) and is expressed in many different 
cell types. The cell-surface glycoprotein (17 kd) is an- 
chored to the cell membrane via a glycophospholipid (Wil- 
liams and Gagnon, 1982; Low and Kincade, 1985; Tse et 
al., 1985), a property shared by an increasing number of 
other cell-surface proteins (for review, see Low et al., 
1986). The antigen has a very complicated expression 
pattern, but was first characterized as a murine T lympho- 
cyte-specific antigen (Reif and Allen, 1964). In the mouse 
it is also found on lymphocyte precursors, including 
pluripotential hematopoietic stem cells (flitter et al., 1980; 
Muller-Sieburg et al., 1986), fibroblasts, and most neurons 
in the central nervous system (see review, Morris, 1985). 
In humans, Thy-l is also expressed in neurons and in 
populations of early T and B cells (flitter et al., 1983); how- 
ever, it is absent from T lymphocytes (Ritter et al., 1983) 
and is present at high levels in kidney (Dalchau and Fabre, 
1979). The rat shows a mixture of the human and mouse 
patterns of expression; it is expressed in brain, in early T 
and B cells, and in the kidney mesangial cells (Morris, 
1985). 
The function of the Thy-l antigen is not known but it has 
been postulated to be involved in cell-cell recognition 
(Williams and Gagnon, 1982; Williams, 1985). Certainly 
Thy-l-specific antibodies can stimulate intracellular cal- 
cium levels and cause proliferation in mouse T cells and 
in transfected 6 cells (Kroczek et al., 1986a, 1986b; Gun-  
ter, 1984). This has led to the suggestion that in T cells 
Thy-l has a proliferative function that is antigen-indepen- 
dent (Kroczek et al., 1986b), taking place via the T%de- 
pendent pathway (Gunter et al., 1987). However,  if Thy-l 
has a proliferative function in hematopoietic cells in gen- 
eral, it would be in very early pre-T cells, since it is not 
present in mature T cells in rat and in humans. In neurons, 
Thy-l only appears well after proliferation lhas ceased, so 
that its role on these cells would not appear to be related 
to cell division (Morris and Beech, 1987). 
The human and mouse Thy-l genes hawe been cloned 
and characterized (Giguere et al., 1985; lngraham and 
Evans, 1986; lngraham et al., 1986; Seki et al., 1985). The 
mouse gene is possibly expressed from ltwo promoters, 
resulting in different untranslated 5’ leader sequences 
(Giguere et al., 1985; lngraham et al., 1986). The promoter 
regions are not tissue-specific, lack a TATA box, and are 
contained in a methylation-free island (Giguere et al., 
1985; lngraham et al., 1986; Kolsto et al., 1986). Several 
tissue-specific extragenic and intragenic sequences are 
required for efficient and cell-type-specific expression 
(Giguere et al., 1985; lngraham arid Evans, 1986; Kollias 
et al., 1987). We have shown previously that a mouse-hu- 
man Thy-l gene can be expressed at high levels in nerve 
cells and thymocytes in transgenic mice (Kollias et al., 
1987), although the gene was not expressed in peripheral 
T cells. To define the &-acting sequencles that are in- 
volved in the tissue-specific expression of the Thy-l gene, 
we introduced a number of mouse-human Thy-l hybrid 
genes into the germline of mice. Analysis of the expres- 
sion patterns of the Thy-l t ransgenes showed consistent 
expression in the mouse kidney tissues, normally nega- 
tive for Thy-l in the mouse but positive in humans. We re- 
port that this inappropriate expression of Thy-l leads to ei- 
ther kidney malfunction or kidney proliferative disorders 
and malfunction. 
Results 
Murine Thy-l Expression in the Glomerulus Causes 
Proteinuria in the Transgenic Mice 
The constructs shown in Figure 1 were injected into fertil- 
ized (CBA x C57BI) Fl mouse eggs (Thy-l.2 background) 
to obtain Thy-1.1, or human Thy-l transgenic mice. The 
first construct (T) contains the murine Thy-l.1 gene in 
which the 3’ untranslated region has been replaced with 
a similar region from the human Thy-l giente. The mature 
Pt’Otein resulting from this transgene is completely Thy-l.1 
and can be distinguished from its allelic form, the endoge- 
nous Thy-1.2, by using monoclonal antibodies (Williams 
and Gagnon, 1982). This construct does not lead to cor- 
rect expression in mature T lymphocytes (Kollias et al., 
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Figure 1. Human-Mouse Hybrid Thy-i Genes 
The top line shows the murine Thy-l.1 gene 
with the different coding regions. The T con- 
structs were made by exchange of the non- 
translated 3’ Apal-EcoRI fraaments of the hu- 
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hT construct contains the murine leader se- 
quences and the human mature protein coding 
sequences. The fragment was injected as an 
EcoRl fragment. Shaded areas indicate human 
DNA sequences. 
1987), so a second construct (mhT) containing additional 
upstream sequences from the murine gene was made 
(Figure 1). The third construct (hT) contains the normal 
murine 3’ untranslated region, but the central part of the 
gene coding for the mature protein has been replaced 
with the homologous part of the human gene. Injections 
of the T construct resulted in four transgenic mice, T6, T9, 
Tll, and T12. TG.had a very high level of expression of the 
transgene and died in infancy; T9 had a low level of ex- 
pression and could be bred to a homozygous animal with 
similar expression patterns to Tll and T12. Tll and T12 
both had multiple copies of the transgene and expressed 
approximately six to ten times the normal level of Thy-l in 
the brain. The expression in lymphoid cells was abnormal 
(Kollias et al., 1987) and will be considered further else- 
where (Kollias, unpublished data). Surprisingly, the pres- 
ence of the human 3’end in the Thy-l.1 transgene caused 
expression in the kidneys of all these animals. Additional 
sequences at the 5’ end (mhT; Figure 1) did not change 
that pattern, and another transgenic animal (mhT4) with 
high expression levels in the kidney was obtained. Three 
other healthy (mhT) animals had nearly lo-fold lower lev- 
els of expression in the kidney on the same cell type. 
These animals did not show any abnormalities and will not 
be considered further. When transgene mRNA levels of 
Tll, T12, and mhT4 are compared with each other (Figure 
2a), it is clear that these animals express the transgene 
and the endogenous gene in brain (Tl2 > Tll > mhT4), but 
only the transgene in kidney. Neither gene is expressed 
in liver (Figure 2a). All T12 mice and the first generation 
of mhT4 developed proteinuria after the first month of life, 
which culminates in severe kidney sclerosis. Different off- 
spring of T12 were analyzed at different times during de- 
velopment to determine levels of Thy-l mRNA in the kid- 
ney, and of proteinuria (Figures 2b, 2~). Between 30 and 
36 days, which is the time of onset of the proteinuria (urine 
analysis, Figure 2c), there is an increase in transgenic 
mRNA in the kidney. By the time the animals develop a 
kidney sclerosis the apparent level of transgene mRNA 
has decreased, because of the destruction of Thy-l-ex- 
pressing cells (see below). At the same time, the level of 
endogenous Thy-l.2 increases above background, be- 
cause of T lymphocyte infiltration, 
Normal mouse kidney is immunohistochemically Thy-l- 
negative (not shown; see also Morris and Ritter, 1980), so 
the very small amount of Thy-l, which can be measured 
by radioimmunoassay, arises either from a generalized, 
very low level of antigen expression, or from T lympho- 
cytes in the blood vessels. In contrast, all the T12, Tll, and 
mhT4 mice examined contained an identical very heavy 
distribution of Thy-l in the glomeruli (Figure 3a) on podo- 
cytes (Figure 3e). Endogenous Thy-l.2 remained unde- 
tectable immunohistochemically. Expression of the trans- 
gene in podocytes was found in T12 mice at 11 days (the 
earliest age investigated) and persisted through the onset 
and course of proteinuria development (Figures 3a, 3c, 
3d). None of the other cell types in the kidney, including 
the mesangial cells of the glomeruli, had detectable trans- 
genie Thy-l.1 associated with them during this period. 
The kidneys of the 20- and 30-day-old mice did not differ 
histologically or ultrastructurally from those of their litter- 
mates (Figure 4a). At 36 days, T12 transgenic mice 
showed minor degrees of (podocyte) foot process swelling 
(Figure 4b) and a slight mesangial deposition of C3, IgM, 
and IgG with the same distribution as that found in the lit- 
termates (not shown). With increasing severity of protein- 
uria (Figure 2c), the animals showed extensive glomerular 
and tubular changes (Figures 3a, 3c, 3d; Figures 4c, 4d). 
The tubules became dilated (Figures 3c, 3d) and were 
found to contain protein casts. The glomerular change is 
best summarized as a severe segmental sclerosis. Changes 
varied a great deal from glomerulus to glomerulus (Fig- 
ures 4c, 4d), with some glomeruli showing areas of lobular 
collapse and an increase of basement membrane-l ike ma- 
terial (Figure 4~). In others, electron dense deposits (Fig- 
ure 4d), mostly in the mesangium but also occasionally as 
large subendothelial accumulations, were a prominent 
feature. Occasional foci of mesangial proliferation were 
seen. Extracapillary proliferation (crescents) and subepi- 
thelial deposits were not seen. In these severely damaged 
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glomeruli there are marked podocyte abnormalities with 
foot process swelling and vacuolation (Figure 4d). Only 
then did the glomeruli show heavy deposits of IgG, IgM, 
and C3 in the mesangial regions. 
The possibility that antiThy-1.1 antibodies might be a 
significant component of the immune response evident in 
the damaged kidneys was investigated using a sensitive 
radioimmunoassay. Serum from four T12 homozygous 
mice aged 8 weeks, which showed heavy proteinuria and 
severe kidney damage, was assayed for antibodies bind- 
ing to both Thy-l.1 and Thy-l.2 thymocytes. To avoid any 
masking of anti-Thy-l.1 antibodies by immune complex 
formation, aliquots of each serum were diluted in 0.5 M 
acetic acid to dissociate such complexes prior to incuba- 
tion with thymocytes. No difference was found between 
such acid-treated serum and aliquots diluted in PBS. Two 
transgenic mice had titers on the Thy-l.l-type thymocytes 
that were indistinguishable from their littermates, or from 
their serum titered on Thy-l.2 thymocytes. The other two 
transgenic mice had the same titer as the rest, but at the 
lowest dilutions showed slightly higher binding to the Thy- 
l.l-type thymocytes. By comparison with control antiThy- 
1.1 antibodies, this was equivalent to 0.04 ug of antibody 
per ml (approximately 2.10T4% of total serum lg). Serum 
from four heterozygotic T12 mice and their littermates at 
28 days of age again showed no differences. 
Expression of Human Thy-l in Murine Kidney 
induces Proliferative Abnormalities 
of Proximal Tubular Epithelium 
injection of the hT construct (Figure 1) resulted in ten posi- 
tive transgenic mice. Three of these, hT27, hT6, and hT16, 
were alive and apparently normal, and hT27 was analyzed 
in detail. Two of the mice, hT1 and hT8, died before they 
could be analyzed; the remaining five mice, hT10, hT13, 
hTd1, hTd4, and hTd5, also died, but could be analyzed in 
detail for the expression of Thy-l. Sl nuclease analysis 
(Figure 5), using probes for the human Thy-l gene and the 
endogenous Thy-l.2 gene, shows that high levels of ex- 
pression of the transgene Thy-l are found in the brain and 
kidney, while the endogenous Thy-l RNA is found only in 
the brain. Again, liver does not show expression of either 
gene. By radioimmunoassay the kidneys were discovered 
to express a level of human Thy-l comparable to that ex- 
pressed by normal human brain (Table 1). hT10, hT13, hTd1, 
hTd4, and hTd5 all developed a cystic neoplasm of Thy-l- 
positive cells, while hT27 has no apparent abnormalities. 
This is not due to a lack of transcription of the transgene, 
since hT27 expressed high levels of intact mRNA (Figure 
5 and Northern blots, not shown), but probably to a sec- 
ondary mutation in the gene, since very little human Thy-l 
could be detected immunohistochemically. 
The kidneys of hT10 and hT13 were analyzed histo- 
logically and immunohistochemically. Both showed neo- 
plasms derived from the proximal tubules through an in- 
termediate in situ tumor. Many tubules show cystic dilation 
(Figure 3f). In some, usually larger, dilated tubules, the ep- 
ithelium maintains a monolayer and is Thy-l-negative (Fig- 
ure 3h). In other tubules, the epithelia have very heavy 
Thy-l deposits at their luminal surface (Figures 3h, 3i), 
with cells often showing an unusual degree of nuclear 
variability, an increase in nuclear size, ancl a high mitotic 
rate, leading to closure of the tubules (Figure 3h). In con- 
trast to the earlier mice containing the T and mhT con- 
structs, podocytes in hTl0 and hT13 kidneys were Thy- 
l-negative (Figure 39). However,  the Thy-+positive in situ 
lesions often extended into glomeruli, which confirmed 
the proximal tubular origin of the lesion. In addition, analy- 
sis of brain tissue of hT13 revealed a papilllomatous neo- 
plasm of the choroid plexus (Figure 6) that filled the third 
and fourth ventricles. The cells showed cytological atypia, 
which we have not yet analyzed in detail. 
Tubular Epithelium Expressing Thy-l Is 
Immortalized in Culture 
Part of an hT10 kidney was put into culture,, where a num- 
ber of morphologically different cell types (Figure 7a) 
proliferated rapidly. Cell lines were derived by repeated 
(two to four) sequences of limiting dilution cloning. Control 
kidney suspensions cultured at the same tilne proliferated 
more slowly and stopped growing completely after 10 
weeks of continuous culture. We could shalw that the htl0 
neoplastic cells are of epithelial origin by the following 
criteria: all cell lines were positive for cytokeratin (e.g., Fig- 
ure 79, 7h) and for the monoclonal 4Fl (Figure 7f) to thy- 
mus cortical epithelia, which also reacts with kidney tubu- 
lar epithelia in vivo (Ritter, unpublished data). Moreover, 
all were negative (or very low) for endogenous Thy-l .2, un- 
like fibroblasts (Stern, 1973). Interestingly, an extensive 
range of cell types could be isolated by using different 
criteria: morphology (Figures 7b-7e), proliferation rate 
(18-48 hr), fibronectin expression (some exclusively cellu- 
lar, others incorporating it into the extracellular matrix; 
Figures 7i, 7j), and the presence of the enzyme D amino 
acid oxidase. This enzyme is present in tubular epithelium 
but not in fibroblasts (Gilbert and Migeon, 1975), and can 
be selected for in media that contain the B form of valine 
only. Although identical to each other by the criteria men- 
tioned above, both resistant and sensitive cell lines were 
isolated. The uncloned cells had abundant human Thy-l 
mRNA (Figure 2) and high Thy-l levels, as measured by 
radioimmunoassay (Table 1). Each of the 36 different cell 
lines that have been derived expresses human Thy-l, in 
levels ranging from 15%-90% of the level found in normal 
human brain (Table 1). Neither the original luncloned cells 
nor any of the lines (six to date) give transplantable tumors 
when introduced into the peritoneal cavity or subcutane- 
ously in nude mice. 
Discussion 
Two purposes can be served by the production of trans- 
genie mice: the elucidation of tissue-specific regulatory 
elements for the gene under study and the analysis of the 
biological role of the gene product. Both aqpects are illus- 
trated by our study. By constructing human--mouse hybrid 
Thy-l genes, we exploited the extensive differences in 
tissue-specific expression that occur between these two 
species. In particular, Thy-l is virtually absent from mu- 
rine kidney (Reif and Allen, 1964; Morris anld Ritter, 1980), 
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Figure 2. Expression of Thy-l in Transgenic Mouse Brain and Kidney 
(a) Measurement of steady-state RNA levels of transgenic mouse tissues carrying the T and mhT gene construct. Ten micrograms of RNA brain 
(B), kidney (K), liver(L), and a human neuroblastoma cell line expressing low amounts of human Thy-i mRNA (NB). The endogenous Thy-l.2 RNA 
is detected as a 115 nucleotide band (mT) and the transgene RNA as a 165 and 400 nucleotide band (hT; see Experimental Procedures). mhT4 Thy-i 
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Figure 3. lmmunocytochemistry for Transgenic Thy-l in Kidneys of T12 (a-e) and hTl0 (F-j) Mice 
lmmunoperoxidase staining for Thy-l.1 (a-e) or human Thy-l (f-j) with thionin counterstaining of nuclei. (a) Cortex of a heterozygous 36-day-old T12 
mouse showing very heavy immunolabeling of glomeruli (e.g., arrows). (b) Control section labeled with second antibody alone. (c) Tl2 heterozygous 
mouse, at 3 months old, showing highly dilated tubules developing (asterisks at right), while the tubules (arrows) and Thy-1.1~labeled glomerulus 
(arrowhead) on the left are still relatively normal. (d) Homozygous 3-month-old mouse, extensive tubular dilation (e.g., asterisks) around three Thy-l .I- 
fabefed glomeruli (arrows). (e) Thy-l.1 labeling of podocytes in glomerulus of a P-month-old heterozygote. An immunolabeled cell (arrow) extends 
its process into the glomerulus; another podocyte process can be seen terminating on a capillary (arrowhead), which at higher mragnification (inset) 
can be seen to contain erythrocytes. (f) lmmunolabeling of dilated tubules (e.g., asterisks) in hTl0 kidney. (g) Glomerulus (MlO) lacks staining for 
human Thy-l, (h) The monolayer of tubular epithelium (arrows) of a large cystic tubule is not labeled for human Thy-l, contrasting with heavy im- 
munolabeling at the luminal face of three smaller tubules, two of which have been closed by epithelial proliferation (curved arrows; asterisk shows 
open Thy-l lined tubule). (i) lmmunolabeling at luminal surface of three tubules. (j) Control section, labeled with second antibody alone. 
Scale bars are 100 firn in (a) and (b); 50 Urn in (c), (d), and (f); and 10 vrn in (e) and (g)-(j). 
but is present at substantial levels (Dalchau and Fabre, the kidney (Kollias et al., 1987), it seemed opportune to ex- 
1979) in human kidney. Since the T construct introduced amine the effect of further human-mouse hybrid Thy-l 
into transgenic mice gave high levels of Thy-l.1 product in genes on kidney expression and function. 
RNA in the kidney is easily visible at higher exposures (see Figure 2b). (b) Expression of T and mhT transgenic mRNA in rnouse kidney tissues 
at several points in development. Br, normal Fi mouse brain RNA. 20, 30, and 36 denotes postnatal development in days. “‘W  signifies adult (7. to 
lo-week-old animals). The sequence p+p-+p+s denotes otherwise healthy T12 animals with increasing levels of proteinuria advancing to very sick 
(S) adult animals (see also Figure 2~). The Sl analysis was carried out as in (a) except that the Hinfl probe for the Thy-l.2 RNA was used (see Ex- 
perimental Procedures). (c) SDS-polyacrylamide gels showing development of proteinuria in T12 transgenic mice (Figure 2b). Urine (5 ~1) was eleo 
trophoresed under nonreducing conditions, and the gels were stained with Coomassie blue. 30,36, and A are as described in Figure 2b. Molecular 
weight markers were reduced samples of ovalbumin (43K), bovine serum albumin (68K), human transferrin (76Q, and rabbit muscle phosphorylase 
B (9X). 
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Figure 4. Ultrastructure of the Transgenic Mouse Kidney 
(a) Glomerulus from a 20-day-old transgenic T12 mouse. The glomerulus appears normal. The podocytes (small arrows) have fine foot processes 
on the capillary loops; the mesangial regions (curved arrow) are of normal cellularity and contain normal amounts of matrix. The mitochondria-rich 
cells (open arrow) lining Bowman’s capsule at one pole are normally present in the mouse. Magnification, 1246x. 
(b) High-power view of a 36-day-old transgenic (T12) mouse (Figure 3a) with proteinuria. The capillary basement membrane (small arrow) and en- 
dothelium (larger arrow) are normal. Most of the foot processes (curved arrows) appear normal, though some appear swollen. Magnification, 
6566.25x. 
(c) Glomerulus from an mhT4 animal with renal failure showing segmental collapse (open arrow). There is an increase of basement membrane-like 
material and electron dense deposits. Podocytes are difficult to find (small arrow) and have a vacuolated cytoplasm. Magnification, 1993.6x. 
(d) Glomerulus from a T12 animal with renal failure. Electron dense deposits in the mesangium (small arrow) are a prominent feature. Podocytes 
are grossly abnormal with marked vacuolation (large arrow). Transgenic T12. Magnification, 2492x. 
We have shown that both the T and mhT constructs give 
high levels of transgenic Thy-l expression in glomerular 
podocytes. Because the expression of endogenous Thy- 
1.2 remains unaffected and the ectopic expression in 
podocytes is observed in all Thy-l-expressing mice carry- 
ing the T or mhT constructs (but not the mouse Thy-l gene 
only or the hT construct), we conclude that the human Thy- 
1 gene 3’segment carries a cis-acting element capable of 
contributing to expression in podocytes. On  the other 
hand, the hT construct that contains a different segment 
of the human Thy-l gene led to high expression of the 
transgene in the kidney proximal tubular epithelium. Simi- 
larly, we conclude that the central part of the human Thy-l 
gene contains c&acting sequences that, in combination 
with the other regulatory elements, direct Thy-l expres- 
sion in proximal tubular epithelium. It should be noted that 
neither construct caused Thy-l expression on the mesan- 
gial cells, on which it is found in the rat (Morris and flitter, 
1980; for review, see Crawford and Barton, 1986). 
Both patterns of ectopic kidney expression produced 
distinct physiological effects. Podocyte expression of the 
T and mhT constructs, at a sufficiently high level (T12, Til, 
mhT4), caused proteinuria in two of the three mouse lines 
(T12, mhT4). These express the highest levels of the T con- 
struct in their kidneys (Table l), although the levels of 
mRNA in mhT4 appear to be lower than those in Tll in Fig- 
ure 2b. This is because the kidneys of this animal were in 
an advanced diseased state and show the same pattern 
of expression as that observed for the T12 adult sick 
animals (Figure 2b), i.e., low transgene but high endoge- 
nous Thy-l expression. Interestingly, the onset of protein- 
uria in T12 is associated with a rise in transgene expres- 
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Figure 5. Measurement of Steady-State mRNA Levels of Transgenic 
Mouse Tissues Carrying the hT Gene Construct 
Top: Ten micrograms of total RNA from a human neuroblastoma cell 
line (NB), brain (B), kidney(K), liver(L), and the kidney cells that were 
derived from the hTl0 neoplasm and established in culture (GRK; see 
text and Figure 7) were hybridized to a 960 nucleotide BstEll-Apal hu- 
man Thy-i probe (Pr). Normal transcription of the hT transgene 
produces an mRNA that protects 320 nucleotides of the above probe 
from Sl digestion (hT). Sizes were estimated from an end-labeled Hinfl 
digest of pBR322 DNA. After longer exposures of the autoradiograph 
(not shown), the positive control lane NE gave a detectable signal at 
the expected size. All other negative lanes remained negative. 
Bottom: The same as top panel but with an 600 nucleotide BstEll-Apal 
mouse fragment as a probe (Pr). In this case only the endogenous Thy- 
1.2 mRNA will protect 320 nucleotides of the probe from Sl nuclease 
digestion (mT). 
sion in the kidney (Figure 2b). This is not caused by 
podocyte proliferation or expression of Thy-i on other cell 
types. Therefore, this suggests that when the Thy-l on the 
podocytes in T12 and mhT4 reaches a certain level, their 
function in maintaining the filtration barrier of the base- 
ment membrane is perturbed, and proteinuria results. 
There are several circumStances in other animals where 
proteinuria follows either a toxic insult or a metabolic ab- 
normality and where the podocyte seems to be the af- 
fected cell. In humans, the spontaneous metabolic abnor- 
mality in Fabry’s disease results in the accumulation of 
ceramide trihexoside in many cells in the body, and the 
podocyte is prominently affected. Proteinuria is present 
and the glomeruli develop focal and segmental hyalinosis 
or sclerosis (Heptinstall, 1978). In the rat, the podocytes ap- 
pear especially sensitive to purine aminonucleoside both 
in vitro (Fishman and Karnovsky, 1985) and in vivo. In the 
Table 1, Levels of Transgenic Thy-i and Endogenous Thy-l .2 
in Brain and Kidney as Measured by Radioimmunoassay 
___~ 
Transgene Endogenous Thy-l .2 
Brain Kidney Brain Kidney 
T Constructs 
T12 6 days 
Littermates 
T12 11 days 
Littermates 
T12 30 days 
Littermates 
T12 60 days 
Littermates 
Til 60 days 
mhT Constructs 
mhT4 5 months 
hT Constructs 
hTl0 
ht13 
hT27 
hTd1 
hTd2 
hTd3 
Littermate to hTdl-3 
GRK cells, uncloned 
16 cell lines selected 
in D-valine 
20 cell lines requiring 
L-valine 
1 .oo 0.035 0.30 0.010 
0 0 0.30 O.cllO 
1 .oo 0.030 0.35 0.006 
0 0 0.4Q 0.006 
6.5 0.030 0.90 0.003 
0 0 0.95 o.ao3 
10.0 0.010 0.95 0.0025 
0 0 1 .oo 0.0025 
6.5 0.010 1 .oo 0.0025 
10.0 0.025 n.d. n.d. 
1.6 
n.d. 
n.d. 
1.00 
0.25 
0.07 
0 
1 .oo 
1.00 
n.d. 
1.00 
1 .oo 
n.d. 
0 
1 .oo 
1.00 
n.d. 
n.d. 
0.20 
0.20 
0.30 
0.25 
0.15-0.65 - 
0.15-0.90 - 
0.0025 
n.d. 
n.d. 
0.002 
n.d. 
n.d. 
0.002 
n.d. 
0.001 
0.001 
Levels are relative to the level in normal adult brain, which is taken 
as 1 .O. Thy-l .I transgene measured in T and mhT mice by absorption 
of OX7 monoclonal antibody, compared to absorption of adult AKR 
mouse brain homogenate. Human Thy-l transgene measured by ab- 
sorption of F15-42-1-5 monoclonal antibody, compared to absorption 
by a sample of human brain homogenate. Endogenous Thy-l .2 mea- 
sured by absorption of 30H-12 monoclonal antibody, compared to ab- 
sorption by adult C57BI x CBA mouse brain homogenate. 
n.d., not determined. 
intact animal, administration of the drug is followed after 
a few days by the development of proteinuria: the podo- 
cytes show striking ultrastructural changes (Caulfield et 
al., 1976). Subsequently, there is the development of 
mesangial hypercellularity, and animals that survive the 
acute phase of the disease subsequently develop wide- 
spread glomerulosclerosis (Diamond and Karnovsky, 1986). 
Interestingly, administration of anti-thymocyte, or anti- 
Thy-l, antibodies in both humans and rats can also lead 
to glomerulonephritis (Cunningham et al., 1987; Ragchus 
et al., 1986; lshizaki et al., 1986). However,  ‘certainly in the 
case of anti-Thy-l antibodies in the rat, ,the mesangial 
cells, rather than the podocytes, constitute the primary 
target tissue, and the disease is immune-related (Bag- 
thus et al., 1986). In our case, there is na evidence for im- 
mune involvement during the onset of proteeinuria, which 
appears to be a direct result of ectopic Thy-l expression. 
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Figure 6. Neoplasm of Choroid Plexus, Im- 
munolabeled for Human Thy-l 
(a) The neoplasm fills the third ventricle and is 
relatively weakly immunoperoxidase-labeled 
for human Thy-l, as compared to strong label- 
ing of axons in the fimbria (arrow) above the 
ventricle. The intense labeling within the neo- 
piasm (arrowheads) is observed with the sec- 
ondary antibody alone (or in the presence of 
anti-Thy-l.1 antibody), and is due to reaction 
with mouse lg in the vasculature of the plexus. 
(b) High-power view of the neoplasm showing 
relatively normal nuclei in the cells around the 
blood vessel (small arrows) and disorganized 
neoplastic cells containing atypical nuclei 
(large arrows). Scale bars are 100 pm (a) and 
IO pm (b). 
In the case of the hT constructs, proteinuria also charac- 
terized the development of a renal abnormality, but in this 
case it is probably the result of glomerular disruption 
caused by invasion of neoplastic proximal tubular epithe- 
lium. The primary lesion appeared to be the uncontrolled 
proliferation of these epithelial cells, giving rise to a cystic 
qeoplasm. The cell lines derived from the hT10 kidney ap- 
pear to be all epithelial, as expected from this neoplasm, 
yet they show several differences in morphology (Figure 
7). Moreover, most proximal tubules in all hT animals de- 
velop this neoplasm, and it seems therefore highly un- 
likely that the neoplasm is the result of a single cell clone 
in each animal, but rather of a population of cells. These 
give rise to different, continually proliferating cell lines in 
culture, each containing high levels of the transgenic Thy- 
1, which suggests an a priori case for the involvement of 
Thy-l in proliferation. Whether the proliferation is the re- 
sult of a blockage of terminal differentiation of tubular epi- 
thelial cells by the expression of Thy-l on their cell sur- 
face, or that Thy-l antigen is the primary stimulator for 
proliferation by an autocrine-type mechanism as, for ex- 
ample, observed for some oncogenes, is not yet clear. 
However,  the fact that all the cells that proliferate in culture 
express Thy-l suggests that the latter might be the case. 
The occurrence of a neoplasm of the choroid plexus epi- 
thelium in one hT animal is particularly intriguing, given 
the similarity of this tissue to the kidney proximal tubules. 
Both tissues are an epithelial monolayer involved in the 
selective interchange of molecules to and from the blood- 
stream. 
Indication of a role for Thy-l in cellular proliferation is 
more advanced in the lymphoid system, where anti-Thy-l 
antibodies, acting through the T3/Ti system on intracellu- 
lar Ca2+ levels, cause proliferation of T lymphocytes 
(Kroczek et al., 1988b; Gunter et al., 1987). It will be in- 
teresting to determine whether a similar pathway is used 
in the proximal tubular epithelium, and why high levels of 
expression of Thy-l fail to reactivate podocytes. 
Experimental Pmcedums 
Hybrid Gene Construction and Pmduction of Transgenic Mice 
The hybrid gene named T (Figure 1) was constructed by fusion of a 5.7 
kb EcoRI-Apal mouse Thy-l.1 gene fragment containing the first four 
exons (including exons la and lb) and part of exon IV to a 3.4 kb 
Apal-EcoRI human Thy-l DNA sequence containing the remaining 
noncoding part of exon IV plus 3’human flanking sequence. The mhT 
hybrid gene was constructed by the addition to the T hybrid gene of 
a 1.3 kb Sall-EcoRI fragment derived from the Yupstream flanking re- 
gion of the mouse Thy-l.1 gene. Finally, the EcoRI-EcoRI fragment 
containing the mouse Thy-l.2 gene was the basis for the construction 
of the hT hybrid gene, which was formed by replacement of a 0.8 kb 
BstEll-Apal fragment containing the coding part of exons Ill and IV 
with the homologous 0.96 kb BstEll-Apal human Thy-l gene fragment. 
Linear DNA fragments were excised from vector sequences with the 
appropriate restriction enzymes, separated on low melting agarose 
gels, isolated, and used for microinjection. F2 hybrid mouse zygotes 
of CBA x C57Bl110 parents were isolated, and pronuclei were injected 
with a solution containing approximately 2 Kg/ml DNA fragments in TE 
buffer (10 mM Tris, pH 7.5; 0.1 mM EDTA). Eggs surviving the microin- 
jection were transferred into the oviducts of recipient pseudopregnant 
females (for review, see Brinster et al., 1985). Ten days after birth, pups 
were analyzed for the presence of intact injected DNA by Southern blot 
analysis of tail genomic DNA (Southern, 1975). 
Purification and Analysis of RNA from Mouse Tissues 
Whole tissues were washed in PBS, and cells were lysed by homogeni- 
zation in 5-10 ml of ice-cold 3 M  LiCI, 6 M  urea (Auffray and Rougeon, 
1980). The homogenate was mixed overnight at 4OC and the next morn- 
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Figure 7. Cell Lines Derived from hTl0 Kidney Have Diverse Epithslial 
Properties 
(a) Phase contrast of primary culture of GRK cells 2 weeks after plating 
out, showing large flat cells surrounded by smaller cells that pile up. 
Scale bar is 50 urn. (b-j) Show cell lines grown for 72 hr on plastic cov- 
erslips and then immunoperoxidase-stained for human Thy-l (b-e), 
monoclonal antibody 4Ft to epithelial cells (f), cytokeratin (g, h), and 
fibronectin (i, j). Cell lines are L9 (b), L4 (c, g. i), D.Fl (d), and D.Ci (f, 
h, j). The prefix “D” denotes a line selected for in D-valine; L, a line that 
requires L-valine. Differences in intensity of staining for human Thy-l 
and cell morphology can be seen (b-e). L4 (i) is typical of some lines 
in secreting extracellular fibronectin, in this case covering four ceils 
D.Cl (j) is typical of other lines for which the fibronectin staining is cellu- 
lar. Antibodies to non-kidney epithelia failed to give any staining (not 
shown). Scale bar (b) is 10 urn; (c-j) are at same magnification. 
ing RNA was pelleted. After a brief wash in 2 ml of the same ice-cold 
LiCI-urea solution and recentrifugation, the RNA pellet was resus- 
pended in 500 ul of a 10 mM Tris (pH 7.6) 1 mM EDTA, 0.5% SDS 
solution followed by phenol/chloroform extraction and ethanol precipi- 
tation. Concentrations were determined from absorbance at 260 nm 
and confirmed by electrophoresis on 2% agarose gels. The latter also 
showed that the RNA preparations were undegraded. $1 nuclease 
analysis of Thy-l-specific mRNA was performed as described else- 
where (Kollias et al., 1967). RNA was hybridized to a 686 nucleotide 
Bamlil (Figure 2a) or 340 nucleotide Hinfl (Figure 2b) 3’ end-labeled 
probe from the 3’end of the Thy-l.2 gene and a 950 nucleotide Ncol- 
Bglll 3’ end-labeled probe from the 3’ end of the human Thy-l gene 
(Pr). Normally, transcription from the endogenous, Thy-l.2 gene pro- 
duces an mRNA that protects a probe fragment of 115 or 210 nucleo- 
tides from Sl nuclease digestion (mT). Normal transcription from the 
T or mhT transgenes produces a major mRNA that protects a probe 
fragment of 165 nucleotides from Sl digestion (hT). A minor band at 
400 nucleotides represents a second poly(A) addition site for the trans- 
genie mRNA (hT). Sizes were estimated from an end-labeled Hinfl di- 
gest of pBR322 DNA (lane M). 
lmmunohistochemical and Histological Analysis 
One kidney from each animal was cut transversely into four sections, 
one of which was snap-frozen by immersion in isopentane/liquid nitro- 
gen, sectioned on a cryostat, and analyzed for deposition of mouse 
IgG, IgM, and third component of complement (fluorescein-conjugated 
sheep anti-mouse IgM and rhodamine-conjugated rabbit anti-mouse 
IgG were from Miles; goat anti-mouse C3 was from Nordic). Another 
segment was fixed by immersion in formalin and processed through 
paraffin wax for histological examination; a third segment was fixed in 
1% glutaraldehydeM% paraformaldehyde in 100 mM phosphate buffer 
(pH 7.4), osmicated, embedded in Epon, and stained in lead citrate be- 
fore examination in the electron microscope. The final segment was 
fixed in 95% ethanol/5% acetic acid and embedded in polyester wax, 
and 5 urn sections were stained for Thy-1.1, Thy-1.:2, or human Thy-l. 
These different forms of Thy-i were detected by using monoclonal anti- 
bodies OX7 (Mason and Williams, 1960) 30H-12 (Ledbetter and Her- 
zenberg, 1979) and F1542-1-5 (Dalchau and Fabre, 1979), respectively. 
In immunohistochemistry these were routinely vilsualized with a horse- 
radish peroxidase-conjugated second antibody, either our own affin- 
ity-purified rabbit F(ab)a anti-mouse IgG (Kollias et ial., 1967) or, for the 
rat monoclonal 30H-12, a rabbit anti-rat IgG (DAKG) that was first ab- 
sorbed with mouse serum to remove antibodies cross-reacting with en- 
dogenous lg in the capillaries, and in damagecl kidneys, the mesan- 
gium. Detection of the transgene products, whether Thy-1.l or human 
Thy-l, was done with mouse monoclonals, and reaction of the second 
antibody was endogenous lg was potentially a problem. However, the 
concentration of both transgenic products was so high in kidney that 
simply using the second antibody at a high dilution (2 uglml) enabled 
visualization of the transgenic Thy-l with minimal detection of endoge- 
nous lg. Use of our normal concentration of second antibody (20 ug/ml) 
gave more intense staining of the transgenic product, and also endog- 
enous lg labeling, but revealed no further cell types expressing the 
transgene. In addition, for detecting the T and mM constructs, we used 
a directly horseradish peroxidase-conjugated F(ab’)s of OX7 antibody, 
and obtained the same pattern of specific labeling as found with the 
indirect conjugates. 
Radioimmunoassays 
These were done as previously described for Thy-l.1 and Thy-i.2 (Kol- 
lias et al., 1967). Human Thy-l was measured by the same method, 
using 0.25 ug/ml of F15-42-1-5 IgG as the first antibody, and residual 
antibody activity remaining after absorption was back-titered onto 100 
pg of human brain membranes. Homogenates of adult AKR, CBA x 
C57B, or human brain were used as standards in measuring Thy-1.1, 
Thy-1.2, and human Thy-l, respectively. Neither mouse brain or kidney, 
or human brain, gave any absorption of the inappropriate monoclonal 
antibodies, even at tissue concentrations up to 1600 times greater than 
that giving absorption of the correct antibody. Similarly, in immuno- 
histochemistry, no cross-reaction of antibodies with1 inappropriate tis- 
sue (e.g., OX7 or F15-42-1-5 with nontransgenic CE3A x C57BI litter- 
mate kidney) was seen. 
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Assessment of Possible Anti-Thy-l.1 Antibodies in T Mice 
Serum was collected from four E-week-old T12 mice homozygous for 
the T construct, and from three nontransgenic littermates. For each, 
50 ul was diluted in 150 PI 0.5 M  acetic acid and incubated for 2 hr at 
4’C. PBS (65 ul) and 2.0 M  Tris (35 pl) were added to neutralize the 
pH, the sample was centrifuged at 14,000 x g for 3 min, and 50 PI ali- 
quots with 11 further doubling dilutions were added to 2.5 x lo6 AKR 
(to measure anti-Thy-1.1) and CBA x C57BI (to measure anti-thymo- 
cyte, including Thy-1.2) antibodies. A separate 50 11 aliquot of each se- 
rum was diluted in 250 ul PBS, and 50 ul of this, with 11 further 
doubling dilutions, was added to each type of thymocyte. After 4 hr the 
thymocytes were washed twice by centrifugation in 0.1% bovine serum 
albumin/PBS, and bound antibody was determined by the binding of 
1251-labeled affinity-purified rabbit F(ab’)z anti-mouse IgG or anti-rat 
IgG (for 30H-12) both at 1 pglml and 10 mCi/mg, in 2% bovine serum 
albumin/PBS (Morris and Williams, 1975). As positive controls, OX7 
IgG (first dilution, 0.5 pg/ml), ascitic fluid containing the IgM monoclo- 
nal anti-Thy-l.1 NIM-Ml31 (Thomas et al., 1986) (first dilution 1:200), 
and 30H-12 (culture supernatant starting from l:iO] were included. In 
a further experiment, serum from four 4-week-old T12 heterozygotic 
mice and three littermates was similarly assayed without acid dissocia- 
tion of immune complexes being included. 
Proteinuria Development 
Samples of urine were collected in microcentrifuge tubes each week, 
and 5 ~1 aliquots were boiled with 20 ul of nonreducing sample buffer 
and electrophoresed on 8% SDS-polyacrylamide gels, which were 
stained with Coomassie brilliant blue. 
Establishment of Cell Lines 
A portion of hTl0 kidney was removed sterilely, teased apart with for- 
ceps in 10% fetal calf serum/RPM1 1640 medium, and cultured at 37oC 
in the same medium. Cells were cloned by limiting dilution in 96-well 
plates, using either the above medium or L-valine-free medium con- 
taining D-valine (Gilbert and Migeon, 1975) to select against fibro- 
blasts. Clones selected in the latter medium were transferred to 5% fe- 
tal calf serum/5% newborn calf serum in RPM1 1640, and are given the 
prefix”D” in their name. Clones selected in normal medium were trans- 
ferred to three wells of a 48-well culture dish. Two of the wells contained 
normal medium; the third contained the D-valine medium. Where 
clones failed to survive in the D-valine medium but reached confluency 
in the two wells containing normal medium, the medium in one of the 
latter was substituted by D-valine medium. If all the cells then died 
(usually over 48 hr), the clone was taken to lack D-amino acid oxidase, 
the enzyme required for survival in medium containing the D, but not 
L, form of valine (Gilbert and Migeon, 1975). Such clones were then 
grown in 5% fetal/5% newborn calf serum, and are given the prefix “LI 
in their name. For all clones, the amount of human Thy-l was mea- 
sured by radioimmunoassay, and the amount of Thy-l.2 similarly mea- 
sured on five D and five L clones. Two L and five D clones were also 
grown on plastic coverslips, fixed in methanol, and immunoperoxi- 
dase-stained for Thy-l.2 and human Thy-l as’before. In addition, these 
cells were stained with antibodies to cytokeratin (DAKO), fibronectin 
(Morris and Beech, 1984) and rat monoclonal antibody 4Fl specific 
for thymic cortical epithelia and renal tubular epithelia (Ritter et al., un- 
published data); the tissue reactivity of this antibody is equivalent to 
the mouse monoclonal antibody MR6 reacting with human epithelium 
(de Maagd et al., 1985). To assess whether these cells gave transplant- 
able tumors, 10’ of the uncloned GRK cells were injected intraperi- 
toneally, or 2 x IOs-1O’cloned cells of three D-type and three L-type 
lines were injected subcutaneously, into two NIMR:NIMR-nv nude 
mice. The mice were followed for 2 months (GRK cells) or one month 
(cell lines) for signs of tumor development. 
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